U.S. government to test Pfizer's Paxlovid for long COVID
- Aryaman Sinha
- Oct 28, 2022
- 1 min read
The U.S. National Institutes of Health's $1 billion RECOVER Initiative has picked Pfizer Inc's (PFE.N) antiviral drug Paxlovid as the first treatment it will study in patients with long COVID, organizers of the study said on Thursday. Awesome!
Photo Credit: danilo.alvesd
Comments